| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Boosting 5-ALA-based photodynamic therapy by a liposomal nanomedicine through intracellular iron ion regulation
|
Li, Airong
|
|
|
11 |
5 |
p. 1329-1340
|
artikel
|
| 2 |
CAR-T cells: Early successes in blood cancer and challenges in solid tumors
|
Dana, Hassan
|
|
|
11 |
5 |
p. 1129-1147
|
artikel
|
| 3 |
Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice
|
Zhu, Yuyu
|
|
|
11 |
5 |
p. 1200-1212
|
artikel
|
| 4 |
Cover Story
|
|
|
|
11 |
5 |
p. ix
|
artikel
|
| 5 |
Design, synthesis, and biological evaluation of Bcr-Abl PROTACs to overcome T315I mutation
|
Jiang, Liang
|
|
|
11 |
5 |
p. 1315-1328
|
artikel
|
| 6 |
Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo
|
Luo, Guoshun
|
|
|
11 |
5 |
p. 1300-1314
|
artikel
|
| 7 |
Energy metabolism disorders and potential therapeutic drugs in heart failure
|
He, Yanan
|
|
|
11 |
5 |
p. 1098-1116
|
artikel
|
| 8 |
Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment
|
Khan, Naveed Ullah
|
|
|
11 |
5 |
p. 1341-1354
|
artikel
|
| 9 |
Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment
|
Shang, Junmei
|
|
|
11 |
5 |
p. 1213-1226
|
artikel
|
| 10 |
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
|
Kiaie, Seyed Hossein
|
|
|
11 |
5 |
p. 1083-1097
|
artikel
|
| 11 |
Inhibiting autophagy enhances sulforaphane-induced apoptosis via targeting NRF2 in esophageal squamous cell carcinoma
|
Lu, Zhaoming
|
|
|
11 |
5 |
p. 1246-1260
|
artikel
|
| 12 |
Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators
|
Lu, Shaoyong
|
|
|
11 |
5 |
p. 1355-1361
|
artikel
|
| 13 |
Multi-omics approaches identify SF3B3 and SIRT3 as candidate autophagic regulators and druggable targets in invasive breast carcinoma
|
Zhang, Shouyue
|
|
|
11 |
5 |
p. 1227-1245
|
artikel
|
| 14 |
Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies
|
Wang, Qin
|
|
|
11 |
5 |
p. 1158-1174
|
artikel
|
| 15 |
New possible silver lining for pancreatic cancer therapy: Hydrogen sulfide and its donors
|
Hu, Xu
|
|
|
11 |
5 |
p. 1148-1157
|
artikel
|
| 16 |
Regulatory control of the Na–Cl co-transporter NCC and its therapeutic potential for hypertension
|
Meor Azlan, Nur Farah
|
|
|
11 |
5 |
p. 1117-1128
|
artikel
|
| 17 |
SMYD3–PARP16 axis accelerates unfolded protein response and mediates neointima formation
|
Long, Fen
|
|
|
11 |
5 |
p. 1261-1273
|
artikel
|
| 18 |
Synergistic integration of metal nanoclusters and biomolecules as hybrid systems for therapeutic applications
|
Gao, Peng
|
|
|
11 |
5 |
p. 1175-1199
|
artikel
|
| 19 |
Table of Contents
|
|
|
|
11 |
5 |
p. iii-viii
|
artikel
|
| 20 |
Targeting BMI-1-mediated epithelial–mesenchymal transition to inhibit colorectal cancer liver metastasis
|
Xu, Zhiyao
|
|
|
11 |
5 |
p. 1274-1285
|
artikel
|
| 21 |
The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy
|
Li, Zhenzhen
|
|
|
11 |
5 |
p. 1286-1299
|
artikel
|
Tijdschrift beschrijving